Kar, SP;
Beesley, J;
Al Olama, AA;
Michailidou, K;
Tyrer, J;
Kote-Jarai, Z;
Lawrenson, K;
... Lambrechts, D; + view all
(2016)
Genome-wide Meta-analyses of Breast, Ovarian and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by At Least Two Cancer Types.
Cancer Discovery
, 6
(9)
pp. 1052-1067.
10.1158/2159-8290.CD-15-1227.
Preview |
Text
Pashayan_Kar et al - GWA metaanalysis of breast, ovarian, prostate ca - Cancer Discovery - accepted version.pdf - Accepted Version Download (505kB) | Preview |
Abstract
Breast, ovarian, and prostate cancers are hormone-related and may have a shared genetic basis but this has not been investigated systematically by genome-wide association (GWA) studies. Meta-analyses combining the largest GWA meta-analysis data sets for these cancers totaling 112,349 cases and 116,421 controls of European ancestry, all together and in pairs, identified at P < 10-8 seven new cross-cancer loci: three associated with susceptibility to all three cancers (rs17041869/2q13/BCL2L11; rs7937840/11q12/INCENP; rs1469713/19p13/GATAD2A), two breast and ovarian cancer risk loci (rs200182588/9q31/SMC2; rs8037137/15q26/RCCD1), and two breast and prostate cancer risk loci (rs5013329/1p34/NSUN4; rs9375701/6q23/L3MBTL3). Index variants in five additional regions previously associated with only one cancer also showed clear association with a second cancer type. Cell-type specific expression quantitative trait locus and enhancer-gene interaction annotations suggested target genes with potential cross-cancer roles at the new loci. Pathway analysis revealed significant enrichment of death receptor signaling genes near loci with P < 10-5 in the three-cancer meta-analysis.
Archive Staff Only
View Item |